Nothing Special   »   [go: up one dir, main page]

CN105616382A - Colloidal bismuth pectin capsule preparation and preparation method - Google Patents

Colloidal bismuth pectin capsule preparation and preparation method Download PDF

Info

Publication number
CN105616382A
CN105616382A CN201610181576.1A CN201610181576A CN105616382A CN 105616382 A CN105616382 A CN 105616382A CN 201610181576 A CN201610181576 A CN 201610181576A CN 105616382 A CN105616382 A CN 105616382A
Authority
CN
China
Prior art keywords
capsules
agent
preparation
capsule
bismuth pectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610181576.1A
Other languages
Chinese (zh)
Inventor
王平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610181576.1A priority Critical patent/CN105616382A/en
Publication of CN105616382A publication Critical patent/CN105616382A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a colloidal bismuth pectin capsule preparation and a preparation process therefor. A capsule shell of the capsule is a hollow capsule shell containing hydroxypropyl starch. The capsule has good dispersion uniformity and uniform drug concentration in a gastric acid environment, and the preparation process is simple.

Description

A kind of Couoidal bismuth pectin capsules preparation and preparation method
Technical field
The present invention relates to the capsule preparations of a kind of Colloidal Bismuth Pectin and its preparation method, it is specially the capsule of a kind of Colloidal Bismuth Pectin adopting hydroxypropylated starch Capsules shell to prepare, belongs to medical art.
Background technology
Tradition gelatine capsule is hydrolyzed obtained animal proteinum colloid gelatin as capsule shell material using the skin of animal, bone, therefore there is multiple security risk. Limited owing to originating, illegal businessman utilizes the processing scrap stock of industrial hides, or the non-leather reclaimed treated made the animal derived Capsules that edible or pharmagel thus supports and may be had that heavy metals exceeding standard, water content are too high, cholesterol levels height and cause the security risks such as animal source transmissible disease.
Therefore, select a kind of safe and effective, quality controllable and possess good pharmacoeconomics be worth capsule preparations, there is irreplaceable use value.
Hydroxypropylated starch capsule then possesses the remarkable advantages such as natural safety, long quality-guarantee period, adaptation be wide. Starch capsule derives from natural cassava, and starch is after denaturing treatment, it is possible to effectively improve the character of starch paste, strengthens the wetting ability of starch paste, the transparency of starch paste and stability is increased to some extent, not easily precipitates, good film-forming property, have excellent toughness. Not only there is many advantages such as raw material sources are natural, security good, wide adaptability, shelf-stable, also avoid the animal source disease of conventional capsules.
Prior art prepares Capsules shell as CN104083768A discloses one, is made up of the composition of following weight proportion: component A: starch and derivative 15-30 part thereof; B component: vegetable jelly 2-13 part; Component C: tinting material 0-5 part. Wherein, starch described in component A and derivative thereof are the combination of starch and hydroxypropylated starch.
Colloidal Bismuth Pectin is a kind of novel colloidal state bismuth preparation, is the salt that biomacromolecule pectic acid (D-polygalacturonic acid) is formed with bismuth metal ion and potassium ion. Colloidal Bismuth Pectin mechanism of action is that it has stronger colloid property; Colloidal Bismuth Pectin is the small molecules acid group that instead of in existing bismuth preparation with biomacromolecule pectic acid; thus change the colloid feature of colloidal bismuth; make it form high viscosity colloidal sol in acidic medium, gastric mucosa is formed one layer of firmly protective membrane.
The barrier action experiment in vitro strengthening gastric mucosa is also it has proven convenient that the collosol property colloidal bismuth more any than other that formed in acidic medium of Colloidal Bismuth Pectin is all good. It can be deposited on the cell walls of helicobacter pylori, makes the cavity having in thalline in various degree, causes cell wall rupture, and the activity of anti-bacteria enzyme, interference bacterial metabolism effect, makes it that the normal defense function of human body is become more responsive.
Colloidal Bismuth Pectin also directly stimulates the generation of prostaglandin(PG) and Urogastron, makes ulcer surface and rotten to the corn face quickly-healing and stops blooding.
But, owing to the viscosity of Colloidal Bismuth Pectin is relatively big, can be agglomerating in water, need vigorous stirring just can scatter, it is diluted with a large amount of weighting agent by prior art usually, but effect is poor, meet water and be still easier to agglomerating.
The present inventor is by experiment, it unexpectedly has been found that Couoidal bismuth pectin capsules prepared by the Capsules shell adopting hydroxypropylated starch to prepare, and can solve the problems of the technologies described above well. Capsule shell and colloid can fully mix even in stomach, form the disintegration point of equal, avoid local drug concentration excessive, cause damage, it is to increase bioavailability.
Summary of the invention
It is an object of the invention to provide that a kind of dispersing uniformity is good in gastric acid environment, drug level even, and the simple Couoidal bismuth pectin capsules agent of preparation technology and preparation technology thereof.
It is an object of the invention to provide a kind of Couoidal bismuth pectin capsules, it is characterised in that capsule shell is for containing hydroxypropylated starch Capsules shell.
As one of specific embodiment of the invention scheme, in the capsule shell of Capsules except hydroxypropylated starch, also can add jelling agent, help the conventional additives such as jelling agent, softening agent, wetting Agent for Printing Inks.
Jelling agent, includes but not limited to gum arabic, xanthan gum, carrageenin, chitosan, trehalose konjak gum, carrageenin;
Help jelling agent, include but not limited to sodium salt or the sylvite of Citric Acid, tartrate, phosphoric acid, acetic acid and ethylenediamine tetraacetic acid (EDTA);
Softening agent, includes but not limited to glycerine, sorbyl alcohol, N.F,USP MANNITOL, triethyl citrate, stearic acid, sucrose, fructose;
Wetting Agent for Printing Inks, includes but not limited to Sodium.alpha.-hydroxypropionate, propylene glycol, poly(oxyethylene glycol) 400, sorbyl alcohol, polyvidone.
As one of specific embodiment of the invention scheme, thing in the capsule of Capsules, except Colloidal Bismuth Pectin, the supplementary additive being suitable for active medicine can be added, include but not limited to weighting agent, lubricant, tackiness agent, disintegrating agent, glidant etc.
Weighting agent, includes but not limited to starch, Microcrystalline Cellulose, lactose, N.F,USP MANNITOL, dextrin, pregelatinized Starch, N.F,USP MANNITOL, sorbyl alcohol etc.
Lubricant, includes but not limited to Magnesium Stearate, talcum powder, Glyceryl Behenate, polyoxyethylene glycol, sodium lauryl sulphate etc.
Tackiness agent, includes but not limited to starch slurry, polyvidone, hypromellose, hydroxypropylcellulose, gum arabic, xanthan gum, Xylo-Mucine etc.
Disintegrating agent, includes but not limited to carboxymethylstach sodium, polyvinylpolypyrrolidone, croscarmellose sodium, low-substituted hydroxypropyl cellulose etc.
Glidant, includes but not limited to silicon-dioxide, talcum powder etc.
Another object of the present invention, it provides a kind of prepare the preparation method containing hydroxypropylated starch Capsules shell, it is characterised in that comprising:
(1) glue is changed: by purified water in entering glue tank, be heated to 80��100 DEG C, then add hydroxypropylated starch, insulated and stirred 90��180min; Then add jelling agent, help jelling agent, softening agent and wetting Agent for Printing Inks, stir 10��15min, add gac and stir decolouring 15min, be filtered in insulated tank temporary;
(2) sol solution obtained is processed into hydroxypropylated starch Capsules shell by full-automatic hollow capsule maker.
Another object of the present invention, it provides a kind of method preparing Couoidal bismuth pectin capsules, it is characterised in that comprise following preparation method:
(1) stock and adjunct taking recipe quantity mixes, and granulates according to feedstock property selectivity, wet granulation or dry granulation;
(2) by the mixed powder or particles filled in capsule shell of preparation.
Accompanying drawing explanation
Hereinafter, come by reference to the accompanying drawings embodiment of the present invention are described in detail, wherein:
Fig. 1 Couoidal bismuth pectin capsules plasma concentration curve figure.
Embodiment
Following examples are the further explanations to the present invention, but never limit the scope of the present invention. Elaborate the present invention further referring to embodiment, but it will be understood and appreciated by those or skill in the art that the present invention is not limited to the preparation method of these embodiments and use. And, the present invention can be carried out equivalent replacement, combination, improvement according to description of the invention or modify by those skilled in the art, but these all will comprise within the scope of the invention.
Embodiment 1Containing the preparation of the capsule shell of hydroxypropylated starch
Prescription:
Supplementary material Consumption
Hydroxypropylated starch 80g
Carrageenin 7g
Chitosan 5g
Sodium Citrate 3.5g
Triethyl citrate 2.7g
Propylene glycol 2g
Preparation method:
(1) glue is changed: by purified water in entering glue tank, be heated to 80��100 DEG C, then add hydroxypropylated starch, insulated and stirred 90��180min; Then add remaining component, stir 10��15min, add gac and stir decolouring 15min, be filtered in insulated tank temporary;
(2) sol solution obtained is processed into hydroxypropylated starch Capsules shell by full-automatic hollow capsule maker.
Comparative example 1aDo not contain the preparation of the capsule shell of hydroxypropylated starch
Prescription:
Supplementary material Consumption
Gelatin 39g
Polyvinyl alcohol 30.75g
Starch succsinic acid 26g
Hydroxyethylamyle 26.25g
Preparation method:
(1) by the supplementary material of recipe quantity, by changing, gluing equipment boiling becomes gelatin solution; Changing glue temperature controls at 56��75 DEG C, is finally 63 DEG C;
(2) it is processed into Capsules shell by full-automatic hollow capsule maker.
Comparative example 1bContaining the preparation of hydroxypropylated starch He other vehicle capsule shell
Prescription:
Supplementary material Consumption
Hydroxypropylated starch 100g
Starch 200g
Gum arabic 8g
Carrageenin 20g
Guar gum 8g
Xanthan gum 20g
Light blue 3g
Preparation method:
(1) get hydroxypropylated starch 100g, starch 200g mix even after, add 90 DEG C of purified water 4L, stir become thick liquid, insulation 2h. Then liquid enters centrifugal spraying spray-dryer and carries out spraying dry, and control inlet temperature is 180 DEG C, and air outlet temperature is 90 DEG C, obtains mixed powder A.
(2) get gum arabic 8g, carrageenin 20g, guar gum 8g, xanthan gum 20g mix even after, add purified water 600ml, stirring becomes thick liquid, add decolorization and impurity removal by active carbon again, filtering, filtrate adds ethanol 280ml and precipitates, filtration under diminished pressure, vacuum-drying under 50 DEG C of conditions, obtains mixed powder B.
(3) 120g mixed powder A, 20g mixed powder B is got and 3g light blue mixes in proportion.
(4) in the powder mixed, add purified water, stir and evenly obtain glue liquid; It is processed into Capsules shell by full-automatic hollow capsule maker.
Comparative example 1cContaining the preparation of the capsule shell of gelatin
Prescription:
Preparation method:
(1) glue is changed: by purified water in entering glue tank, be heated to 80��100 DEG C, then add gelatin, insulated and stirred 90��180min; Then add jelling agent, help jelling agent, softening agent and wetting Agent for Printing Inks, stir 10��15min, add gac and stir decolouring 15min, be filtered in insulated tank temporary;
(2) sol solution obtained is processed into hydroxypropylated starch Capsules shell by full-automatic hollow capsule maker.
Embodiment 2aPrepare thing in the capsule of Couoidal bismuth pectin capsules
Specification 50mg batch 1000
Prescription
Component Weight
Colloidal Bismuth Pectin 50g
Microcrystalline Cellulose 50g
PVP K30 2g
Purified water 18g
Magnesium Stearate 1g
Preparation process:
(1) tackiness agent preparation: the PVP K30 of recipe quantity is dissolved in as tackiness agent in purified water, for subsequent use;
(2) batch mixing: the Colloidal Bismuth Pectin and the Microcrystalline Cellulose that take recipe quantity cross 60 order sieves, are mixed to evenly;
(3) granulate: tackiness agent is added softwood processed in above-mentioned mixed powder, cross 24 order sieves and granulate;
(4) dry: above-mentioned wet granular is placed in 60 DEG C of forced air dryings 1 hour;
(5) whole grain: with 24 order sieves, dried particle is carried out whole grain, obtain thing in required capsule capsule.
Embodiment 2bPrepare thing in the capsule of Couoidal bismuth pectin capsules
Specification 50mg
Batch 1000
Prescription
Preparation process:
(1) Colloidal Bismuth Pectin and diatomite being added in ball mill and pulverize, must contain medicine adsorptive, control is less than 30 microns containing the median size of medicine adsorptive;
(2) step (1) gained is mixed with polyvinylpolypyrrolidone, sodium stearyl fumarate containing medicine adsorptive, obtain thing in required capsule capsule.
Embodiment 2cPrepare thing in the capsule of Couoidal bismuth pectin capsules
Specification 50mg
Batch 1000
Prescription:
Component Weight
Colloidal Bismuth Pectin 50g
Acrylic resin IV 35g
Light calcium carbonate 10g
Ethanol 900g
Preparation process:
(1) being dissolved in ethanol by acrylic resin IV, add light calcium carbonate and stir evenly, clarifixator processes, for subsequent use;
(2) Colloidal Bismuth Pectin is added in fluidized-bed, adopt spray coating method at the bottom of fluidized-bed to spray into the suspension dressing of step (1), inlet temperature 35 DEG C, atomizing pressure 0.3-0.4MPa, liquid feeding pump rotating speed 10-15rpm. Dressing is complete, puts burin-in process 12h in 50 DEG C of baking ovens, obtains Colloidal Bismuth Pectin coated micropill;
(3) by micro-ball obtained for step (2) respectively with 40 orders, 80 order sieve screenings, 40 order-80 micro-balls of order are got, i.e. thing in required capsule capsule.
Embodiment 3 prepares Couoidal bismuth pectin capsules
Thing in the capsule of preparation in the capsule shell of preparation in embodiment 1 and comparative example 1a-1c and embodiment 2a-2c is combined, is prepared as follows sample.
Preparation method:
By thing in the capsule capsule of embodiment 2a-2c, it is respectively charged into embodiment 1, in the Capsules shell of comparative example 1a-1c.
Test example 1 study on the stability
Sample 2a1-2c1c is amounted to 12 samples detect, is then placed in 40 DEG C �� 2 DEG C, place 6 months under relative humidity 75% �� 5% condition, respectively at 1,2,3, detection in June, the content of detection Colloidal Bismuth Pectin and disintegration, the results are shown in following table 1��2:
Table 1: content detection result (%)
Time 2a1 2b1 2c1 2a1a 2b1a 2c1a 2a1b 2b1b 2c1b 2a1c 2b1c 2c1c
0 month 99. 99.6 99.9 99.7 99.8 99.8 99.7 99.6 99.7 99.9 99.8 99.9
1 month 99.7 99.6 99.9 99.0 99.1 99.4 99.7 99.6 99.5 99.1 98.9 99.2
2 months 99.6 99.5 99.7 98.4 98.5 98.7 99.4 99.4 99.3 98.5 98.4 98.3
3 months 99.5 99.3 99.4 97.0 97.1 97.7 99.2 99.1 99.1 97.9 97.4 97.9
6 months 99.3 99.1 99.2 95.1 96.4 96.5 99.1 98.9 99.0 97.1 96.4 97.5
Table 2: disintegration detected result
Conclusion: above-mentioned test-results shows, sample puts 40 DEG C �� 2 DEG C, place 6 months under relative humidity 75% �� 5% condition, the content of 2a1,2b1,2c1,2a1b, 2b1b, 2c1b six samples and disintegration considerable change does not occur, and obvious change all occur in other six samples, content reduction and disintegration are elongated. Because the capsule shell of 2a1,2b1,2c1,2a1b, 2b1b, 2c1b sample does not all contain in other six sample capsules shells this composition containing hydroxypropylated starch, therefore, this test demonstrates and adopts that to prepare the quality of Couoidal bismuth pectin capsules agent containing the capsule shell of hydroxypropylated starch more excellent, and character is stablized unexpectedly.
Test example 2 dissolution in vitro detects
Sample 2a1-2c1c being amounted to 12 samples and carries out dissolution in vitro detection, result is as follows:
Table 3: dissolution rate detected result
Brief summary: from above-mentioned testing data, the Couoidal bismuth pectin capsules of the different prescriptions that the Capsules containing hydroxypropylated starch adopting embodiment 1 and comparative example 1b to prepare is made, its dissolution in vitro is greater than the Couoidal bismuth pectin capsules that comparative example 1a and comparative example 1c does not make containing the Capsules of hydroxypropylated starch, has absolutely proved that the Couoidal bismuth pectin capsules that the present invention adopts hydroxypropylated starch capsule shell to prepare is improving the superiority in dissolution in vitro.
Test example 3 bioavailability
Sample 2a1-2c1c is amounted to 12 samples and carries out bioequivalence test in body, Plasma Concentration is detected, the results are shown in accompanying drawing 1.
Conclusion: from accompanying drawing 1, the Couoidal bismuth pectin capsules of the different prescriptions that the Capsules containing hydroxypropylated starch adopting embodiment 1 and comparative example 1b to prepare is made, in its body, Plasma Concentration is greater than the Couoidal bismuth pectin capsules that comparative example 1a and comparative example 1c does not make containing the Capsules of hydroxypropylated starch, has absolutely proved that Couoidal bismuth pectin capsules that the present invention adopts hydroxypropylated starch capsule shell to prepare is improving in body the superiority in bioavailability.

Claims (5)

1. a Couoidal bismuth pectin capsules preparation, it is characterised in that capsule shell is the Capsules shell containing hydroxypropylated starch.
2. Couoidal bismuth pectin capsules preparation according to claim 1, it is characterised in that in described Capsules shell except hydroxypropylated starch, also can add jelling agent, help the conventional additives such as jelling agent, softening agent, wetting Agent for Printing Inks.
3. Couoidal bismuth pectin capsules preparation according to the arbitrary item of claim 1-3, it is characterized in that thing in capsule, except Colloidal Bismuth Pectin, the supplementary additive being suitable for active medicine can be added, include but not limited to weighting agent, lubricant, tackiness agent, disintegrating agent, glidant etc.
4. prepare the method for Couoidal bismuth pectin capsules for one kind, it is characterised in that comprising:
(1) stock and adjunct taking recipe quantity mixes, and granulates according to feedstock property selectivity, wet granulation or dry granulation;
(2) by the mixed powder or particles filled in capsule shell of preparation.
5. method according to claim 4, it is characterised in that, the preparation method of described capsule shell is as follows:
(1) glue is changed: by purified water in entering glue tank, be heated to 80��100 DEG C, then add hydroxypropylated starch, insulated and stirred 90��180min; Then add jelling agent, help jelling agent, softening agent and wetting Agent for Printing Inks, stir 10��15min, add gac and stir decolouring 15min, be filtered in insulated tank temporary;
(2) sol solution obtained is processed into hydroxypropylated starch Capsules by full-automatic hollow capsule maker.
CN201610181576.1A 2016-03-28 2016-03-28 Colloidal bismuth pectin capsule preparation and preparation method Pending CN105616382A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610181576.1A CN105616382A (en) 2016-03-28 2016-03-28 Colloidal bismuth pectin capsule preparation and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610181576.1A CN105616382A (en) 2016-03-28 2016-03-28 Colloidal bismuth pectin capsule preparation and preparation method

Publications (1)

Publication Number Publication Date
CN105616382A true CN105616382A (en) 2016-06-01

Family

ID=56032012

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610181576.1A Pending CN105616382A (en) 2016-03-28 2016-03-28 Colloidal bismuth pectin capsule preparation and preparation method

Country Status (1)

Country Link
CN (1) CN105616382A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075270A (en) * 2019-05-27 2019-08-02 伟日(山东)生物科技有限公司 Inhibit the nisin enteric coatel tablets and preparation method thereof of helicobacter pylori
CN110200935A (en) * 2019-06-03 2019-09-06 浙江得恩德制药股份有限公司 A kind of Couoidal bismuth pectin capsules and its preparation process

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090247486A1 (en) * 2008-03-26 2009-10-01 Serizawa Yuriko Composition for oral substance coating, covering material for oral substance, edible container and oral substance using the same
CN103893772A (en) * 2014-04-21 2014-07-02 湖南同泰胶囊有限公司 Hydroxypropyl starch empty capsules and preparation process thereof
CN103937037A (en) * 2014-04-28 2014-07-23 中国科学院化学研究所 Modified starch adhesive for preparing hollow capsule and starch-base hollow capsule thereof
CN104083768A (en) * 2014-07-02 2014-10-08 湖南尔康制药股份有限公司 Premix auxiliary and preparation method thereof
CN104116721A (en) * 2014-08-08 2014-10-29 严白双 Colloidal bismuth pectin capsule and preparation process thereof
CN104825419A (en) * 2015-05-27 2015-08-12 浙江得恩德制药有限公司 Low-moisture-absorption colloidal bismuth pectin capsule and preparation technology thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090247486A1 (en) * 2008-03-26 2009-10-01 Serizawa Yuriko Composition for oral substance coating, covering material for oral substance, edible container and oral substance using the same
CN103893772A (en) * 2014-04-21 2014-07-02 湖南同泰胶囊有限公司 Hydroxypropyl starch empty capsules and preparation process thereof
CN103937037A (en) * 2014-04-28 2014-07-23 中国科学院化学研究所 Modified starch adhesive for preparing hollow capsule and starch-base hollow capsule thereof
CN104083768A (en) * 2014-07-02 2014-10-08 湖南尔康制药股份有限公司 Premix auxiliary and preparation method thereof
CN104116721A (en) * 2014-08-08 2014-10-29 严白双 Colloidal bismuth pectin capsule and preparation process thereof
CN104825419A (en) * 2015-05-27 2015-08-12 浙江得恩德制药有限公司 Low-moisture-absorption colloidal bismuth pectin capsule and preparation technology thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
吴国庆: "一种新型植物空心胶囊的研制", 《明胶科学与技术》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075270A (en) * 2019-05-27 2019-08-02 伟日(山东)生物科技有限公司 Inhibit the nisin enteric coatel tablets and preparation method thereof of helicobacter pylori
CN110200935A (en) * 2019-06-03 2019-09-06 浙江得恩德制药股份有限公司 A kind of Couoidal bismuth pectin capsules and its preparation process
CN110200935B (en) * 2019-06-03 2021-03-02 浙江得恩德制药股份有限公司 Colloidal bismuth pectin capsule and preparation process thereof

Similar Documents

Publication Publication Date Title
KR100526285B1 (en) Cellulosic particle for pharmaceutical preparation
US5674532A (en) Pancreatin preparations
JP2008007458A (en) Core particle for layering and method for producing the same
EP0285682B2 (en) Process for the manufacture of vitamin preparations
CN1235824A (en) Process for producing enteric coated pancreatin granules
CN107802612B (en) Omeprazole enteric-coated pellets and capsules and preparation method thereof
JPH0428691B2 (en)
CN102525990A (en) Ilaprazole enteric-coated tablets and preparation method thereof
CN105616382A (en) Colloidal bismuth pectin capsule preparation and preparation method
CN111067096A (en) Porous starch microcapsule embedding lutein and preparation method thereof
Sopanrao Muley et al. Formulation and optimization of lansoprazole pellets using factorial design prepared by extrusion-spheronization technique using carboxymethyl tamarind kernel powder
CA2100295C (en) A psyllium-hydrocolloid gum composition
CN104686808A (en) 50% enteric package zinc oxide nanoparticle preparation method
US20090304800A1 (en) Dry Coating using Twin-Screw Kneader
CN102008492A (en) Oral medicinal composition of glycyrrhizic acid or glycyrrhetate and preparation method thereof
CN109568284A (en) A kind of tenofovir Chinese mugwort draws phenol amine enteric coatel tablets and preparation method thereof
CN105832701B (en) Aureomycin microcapsule premix and preparation method thereof
CN104825419B (en) A kind of agent of low hygroscopicity Couoidal bismuth pectin capsules agent and its preparation technology
CN104606139B (en) A kind of preparation and application of drug powder
CN105796526A (en) Cephalosporin medicine capsule and preparing method thereof
CN105726509A (en) Pantozol medicine capsule
CN103845323B (en) Mycophenolic Acid and its salt enteric coated preparations and preparation method
CN105832694A (en) Penicillins medicine capsule and preparation method of same
CN107982235A (en) A kind of indapamide tablets and preparation method thereof
CN105832695A (en) Tizol-series medicine capsule

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160601

WD01 Invention patent application deemed withdrawn after publication